This inventor holds 2 USPTO granted patents and 2 published patent applications. Top assignee: Hyloris Developments Sa. Active years: 2022-2023.
Location History:
- Liège, BE (2022)
- Leuven, BE (2023)
Company Filing History:
Years Active: 2022-2023
Title: Innovations by Thomas Gerner Jacobsen
Introduction
Thomas Gerner Jacobsen is a notable inventor based in Leuven, Belgium. He has made significant contributions to the field of pharmaceuticals, particularly in developing compositions that address bleeding disorders and pain management. With a total of 2 patents, Jacobsen's work reflects his commitment to improving patient care through innovative solutions.
Latest Patents
Jacobsen's latest patents include a method for treating patients with bleeding disorders during dental procedures. This invention provides a tranexamic acid oral solution that reduces bleeding and the need for factor replacement therapy. The composition includes tranexamic acid, sodium carboxymethyl cellulose, Tween® 20, and menthol, ensuring long-term stability and reduced bitterness compared to traditional solutions. Another significant patent involves a method for preparing an intravenously administrable aqueous composition containing acetaminophen and optionally one or more NSAIDs. This method focuses on maintaining low dissolved oxygen content to enhance the efficacy of the composition.
Career Highlights
Jacobsen is currently associated with Hyloris Developments SA, where he continues to innovate in the pharmaceutical sector. His work is characterized by a strong emphasis on patient safety and comfort, particularly in the context of pain management and bleeding control.
Collaborations
Throughout his career, Jacobsen has collaborated with esteemed colleagues, including Mary Beth G Erstad and Mohammad Alkhalili. These partnerships have contributed to the advancement of his research and the successful development of his patents.
Conclusion
Thomas Gerner Jacobsen's contributions to pharmaceutical innovations demonstrate his dedication to enhancing patient outcomes. His patents reflect a blend of scientific expertise and practical application, making a significant impact in the medical field.